🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, newly diagnosed non-elderly patients with Philadelphia chrom...
Status
Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2024-02-05
Trial ID
NCT06250959
Treatments Being Tested
In this phase I study, escalating doses of IXAZOMIB will be combined with t...
Status
Withdrawn
Location
Froedtert & the Medical College of Wisconsin
Start Date
2017-06-29
Trial ID
NCT02578511
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of bortezomib ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2007-04-03
Trial ID
NCT00477412
Treatments Being Tested
The main purpose of this study is to evaluate the safety and efficacy of Ri...
Status
Completed
Location
Ruijin Hospital
Start Date
2010-12
Trial ID
NCT01358253
The purpose of the study is to evaluate the safety and tolerability of the ...
Status
Recruiting
Location
Moffitt Cancer Center
Start Date
2023-05-01
Trial ID
NCT05581030
Treatments Being Tested
The main objective of this trial is to demonstrate that subcutaneous (SC) b...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-11
Trial ID
NCT07223190
Treatments Being Tested
The purpose of this study is to establish a model which can predict the tre...
Status
Completed
Location
Samsung Medical Center
Start Date
2008-09
Trial ID
NCT00822731
Treatments Being Tested
Various drugs have been added to different treatment regimens in order to i...
Status
Unknown
Location
Hospital General de México "Dr. Eduardo Liceaga"
Start Date
2021-12-12
Trial ID
NCT05137860
Treatments Being Tested
The experimental group included patients diagnosed with T-ALL/LBL (T-lympho...
Status
Recruiting
Location
Shanghai General Hospital
Start Date
2024-08-07
Trial ID
NCT06598722
rituximab and modified (hyperCVAD) administered every 28 days for 4-6 cycle...
Status
Completed
Location
UWCCC
Start Date
2000-06
Trial ID
NCT00581854
Treatments Being Tested